The Three Letters That Kill Social Media in Pharma
An interview I did recently for an organisation conducting some research into…
Moving Towards Personalized Care with Healthcare’s Biggest Advocates
When my daughter Casey was born with nail-patella syndrome (NPS), the orthopedic…
The Struggle for Consumer Attention: Brand-Name Drugs vs. Generics
“Is there a generic version of that?” “Is there a generic version…
Research and Development in Pharma: 4 Lessons in Change
This is the eleventh blog post in a twelve part series that…
_3.jpg)
The Price, Cost, and Value of Bio-Pharmaceutical Care
“Confusion” and “Misunderstanding” are two of the words one can use to…
Where There Is Research, There Is Hope
Attending the second annual Research and Hope Awards, run by the Pharmaceutical…
Three Ways to Supersize Your Patient KOL Strategy
This is the fifth blog post in a twelve part series that…
Is a Daily Dose of Many Pills in Your Future?
In the hustle and bustle of our daily lives we don’t tend…
Oral Anticancer Law: Unintended Consequence
I scratched my head when I received a letter today from Blue…
